Exploring the interplay between cannabinoids and thymic functions

被引:0
作者
Lins, Marvin Paulo [1 ,2 ]
de Melo, Igor Santana [3 ]
机构
[1] Univ Fed Mato Grosso, Fac Med, Dept Basic Sci Hlth, Lab Immunol, Cuiaba Campus,Fernando Correa Costa Ave,236, BR-78060900 Cuiaba, MT, Brazil
[2] Fundacao Oswaldo Cruz, Brazilian Natl Inst Sci & Technol Neuroimmunomodul, BR-21040360 Rio De Janeiro, Brazil
[3] Univ Fed Alagoas, Inst Biol & Hlth Sci, Lab Neuropharmacol & Integrat Physiol, BR-57072900 Maceio, Brazil
关键词
Cannabis research; cannabidiol; tetrahydrocannabinol; thymus; thymocyte; KAPPA-B; ORAL DELTA(9)-TETRAHYDROCANNABINOL; CELL DEVELOPMENT; IMMUNE-SYSTEM; CB1; RECEPTORS; CANNABIDIOL; DELTA-9-TETRAHYDROCANNABINOL; THC; PHARMACOLOGY; MARIJUANA;
D O I
10.1093/toxsci/kfae114
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cannabinoids, derived from the Cannabis sativa plant, have garnered increasing attention for their potential therapeutic applications in various diseases. The pharmacologically active compounds in Cannabis, such as delta-9-tetrahydrocannabinol and cannabidiol, exhibit diverse immunomodulatory properties. Although studies have explored the effects of cannabinoids on immune function, their specific interactions with the thymus, a primary immune organ critical for T-cell development and maturation, remain an intriguing area of investigation. As the thymus plays a fundamental role in shaping the immune repertoire, understanding the interplay between cannabinoids and thymic function may shed light on potential benefits or concerns associated with Cannabis-based therapies. This article aims to provide an overview of the current scientific knowledge regarding the impact of medicinal Cannabis on the thymus and its implications for disease treatment and immune health.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 112 条
[21]  
Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725
[22]   CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate enerpv balance, metabolism, and cardiovascular health [J].
Cota, Daniela .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2007, 23 (07) :507-517
[23]   Keep off the grass? Cannabis, cognition and addiction [J].
Curran, H. Valerie ;
Freeman, Tom P. ;
Mokrysz, Claire ;
Lewis, David A. ;
Morgan, Celia J. A. ;
Parsons, Loren H. .
NATURE REVIEWS NEUROSCIENCE, 2016, 17 (05) :293-306
[24]   Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users [J].
Curran, HV ;
Brignell, C ;
Fletcher, S ;
Middleton, P ;
Henry, J .
PSYCHOPHARMACOLOGY, 2002, 164 (01) :61-70
[25]   The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis [J].
D'Souza, DC ;
Perry, E ;
MacDougall, L ;
Ammerman, Y ;
Cooper, T ;
Wu, YT ;
Braley, G ;
Gueorguieva, R ;
Krystal, JH .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) :1558-1572
[26]   CBG, CBD, δ9-THC, CBN, CBGA, CBDA and δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action [J].
Dawidowicz, Andrzej L. ;
Olszowy-Tomczyk, Malgorzata ;
Typek, Rafal .
FITOTERAPIA, 2021, 152
[27]   Maternal exposure to the synthetic cannabinoid HU-210:: Effects on the endocrine and immune systems of the adult male offspring [J].
del Arco, I ;
Muñoz, R ;
de Fonseca, FR ;
Escudero, L ;
Martín-Calderón, JL ;
Navarro, M ;
Villanúa, MA .
NEUROIMMUNOMODULATION, 2000, 7 (01) :16-26
[28]   Cannabidiol markedly alleviates skin and liver fibrosis [J].
del Rio, Carmen ;
Ruiz-Pino, Francisco ;
Prados, Maria E. ;
Fiebich, Bernd L. ;
Tena-Sempere, Manuel ;
Munoz, Eduardo .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[29]   Immunosuppressive activity of non-psychoactive Cannabis sativa L. extract on the function of human T lymphocytes [J].
Devi, Seema ;
Zimmermann-Klemd, Amy M. ;
Fiebich, Bernd L. ;
Heinrich, Michael ;
Gruendemann, Carsten ;
Steinberger, Peter ;
Kowarschik, Stefanie ;
Huber, Roman .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 103
[30]   CANNABINOIDS IN GLAUCOMA - A PRIMARY SCREENING-PROCEDURE [J].
ELSOHLY, MA ;
HARLAND, E ;
MURPHY, JC ;
WIRTH, P ;
WALLER, CW .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S472-S478